CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Severance Costs (Deprecated 2013-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Severance Costs (Deprecated 2013-01-31) of $582.00 thousand for the 6-month period ending 2013-06-29, per its 10-Q filed 2013-07-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts · last filed 2013-07-31
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. severance costs (deprecated 2013-01-31) for the quarter ending 2013-06-29 was $285.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. severance costs (deprecated 2013-01-31) for the quarter ending 2013-03-30 was $297.00K, a 67.40% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. severance costs (deprecated 2013-01-31) for the quarter ending 2012-12-29 was $695.00K, a 83.23% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. severance costs (deprecated 2013-01-31) for the quarter ending 2012-09-29 was $970.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. severance costs (deprecated 2013-01-31) for fiscal 2012 was $2.58M, a 52.84% decline from fiscal 2011.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. severance costs (deprecated 2013-01-31) for fiscal 2011 was $5.46M, a 66.90% decline from fiscal 2010.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. severance costs (deprecated 2013-01-31) for fiscal 2010 was $16.50M, a 0.98% increase from fiscal 2009.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. severance costs (deprecated 2013-01-31) for fiscal 2009 was $16.34M.
| Period end | Severance Costs (Deprecated 2013-01-31) 3 month | Severance Costs (Deprecated 2013-01-31) 6 month | Severance Costs (Deprecated 2013-01-31) 9 month | Severance Costs (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-06-29 | $285.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $582.00K 10-Q · filed 2013-07-31 | $1.28M derived: sum of 3 quarters · filed 2013-07-31 | $2.25M derived: sum of 4 quarters · filed 2013-07-31 |
| 2013-03-30 | $297.00K 10-Q · filed 2013-05-08 | $992.00K derived: sum of 2 quarters · filed 2013-05-08 | $1.96M derived: sum of 3 quarters · filed 2013-05-08 | $1.96M derived: sum of 4 quarters · filed 2013-07-31 |
| 2012-12-29 | $695.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $1.67M derived: sum of 2 quarters · filed 2013-02-27 | $1.67M derived: sum of 3 quarters · filed 2013-07-31 | $2.58M 10-K · filed 2013-02-27 |
| 2012-09-29 | $970.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $970.00K derived: sum of 2 quarters · filed 2013-07-31 | $1.88M 10-Q · filed 2012-11-01 | $6.03M derived: sum of 4 quarters · filed 2013-07-31 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $911.00K 10-Q · filed 2013-07-31 | $5.06M derived: sum of 3 quarters · filed 2013-07-31 | $4.98M derived: sum of 4 quarters · filed 2013-07-31 |
| 2012-03-31 | $911.00K 10-Q · filed 2013-05-08 | $5.06M derived: sum of 2 quarters · filed 2013-05-08 | $4.98M derived: sum of 3 quarters · filed 2013-05-08 | $5.88M derived: sum of 4 quarters · filed 2013-05-08 |
| 2011-12-31 | $4.14M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $4.07M derived: sum of 2 quarters · filed 2013-02-27 | $4.97M derived: sum of 3 quarters · filed 2013-02-27 | $5.46M 10-K · filed 2013-02-27 |
| 2011-09-24 | -$75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $823.00K derived: sum of 2 quarters · filed 2012-11-01 | $1.32M 10-Q · filed 2012-11-01 | $12.25M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-25 | $898.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $1.39M 10-Q · filed 2012-08-07 | $12.32M derived: sum of 3 quarters · filed 2013-02-27 | $13.08M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-26 | $494.00K 10-Q · filed 2012-05-04 | $11.43M derived: sum of 2 quarters · filed 2013-02-27 | $12.18M derived: sum of 3 quarters · filed 2013-02-27 | |
| 2010-12-25 | $10.93M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $11.69M derived: sum of 2 quarters · filed 2013-02-27 | $16.50M 10-K · filed 2013-02-27 | |
| 2010-09-25 | $756.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $5.57M 10-Q · filed 2011-11-02 | ||
| 2010-06-26 | $4.82M 10-Q · filed 2011-08-03 | |||
| 2009-12-26 | $16.34M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |